Uzbekistan Digital Health Platform, published by Ministry of Health of the Republic of Uzbekistan. This guide is not an authorized publication; it is the continuous build for version 0.11.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/uzinfocom-org/digital-health-ig/ and changes regularly. See the Directory of published versions
Home
Official URL: https://dhp.uz/fhir/core/ImplementationGuide/uz.dhp.core
This FHIR R5 implementation guide (IG) is a work in progress and is not yet ready for production use. It is intended for testing and feedback purposes only of the Digital Health Platform (DHP). The content is subject to change as the IG is developed further.
Current priority is on completing the core resource profiles first to enable their implementation in DHP. Afterwards, when sufficient modelling capability is available, the rest of the IG prose will be fleshed out.
Introduction
This guide is the official source of documentation for the implementation of FHIR within the framework of Uzbekistan's Digital Health Platform, and it has been adapted to the realities, needs, and specific features of the national healthcare system.
The guide serves as a foundation for:
Developing UZ Core profiles that adapt FHIR resources to local needs in Uzbekistan and establish a common baseline of support digital healthcare in the republic;
such adaptations include modelling common identifiers, translations of HL7 codesystems, and marking elements that must be supported by all systems
Developing usecase-specific profiles to support specific clinical and administrative scenarios;
such as the Birth and Death registry
Utilising international and national classifications and terminologies (SNOMED-CT, LOINC, ICD-10, ICD-11, CBPEPW-2020).
Using this IG will help ensure consistency in the representation of medical data, enhance system interoperability, and establish a solid foundation for a scalable digital health ecosystem.
Project background
The Digital Health Platform (DHP) is being developed within the framework of the "Support for Healthcare Digitalization Reform" project, implemented under the agreement between the Republic of Uzbekistan and the KfW Development Bank. This initiative is in line with the Presidential Decree of the Republic of Uzbekistan No. PP-140 dated May 1, 2023, "On Additional Measures for the Digitalization of the Healthcare System" and Resolutions of the President of the Republic of Uzbekistan No. PP-415 dated December 28, 2023 "On additional measures to accelerate the digitalization of the healthcare system and the introduction of advanced digital technologies".
Areas of coverage
The Digital Healthcare Platform of the Republic of Uzbekistan is based on the following 19 components:
Artifacts such as profiles, extensions, codesystems, valuesets, naming systems, and the FHIR package in this IG follow the version of the IG itself. The IG versioning is based on Semantic Versioning (SemVer) principles in the format of MAJOR.MINOR.PATCH. For example, all artifacts in version 2.0.0 of the IG will have the same version number 2.0.0. This allows for easy identification of which version of the IG an artifact belongs to.
While an artifact is in development and not yet ready for production use, it will have a status of draft. Once the artifact is ready for production use, it will be marked as active. If an artifact has been retired, it will have a status of retired.
A maturity model for testing artifacts in the real world will be introduced in the future, but for now, all artifacts are considered draft until they are ready for production use.
The only exception to versioning are translation supplements of official THO codesystems, which follow the versioning of the original codesystem. For example, if the THO codesystem version is at 2.1.0, the supplement will be at 2.1.0 as well, regardless of the IG version. If the THO codesystem is updated to 2.2.0, the supplement will be updated to 2.2.0 as well. If a supplement needs to be updated while the THO codesystem remains unchanged an extra version number will be added to the supplement, e.g. 2.2.0.1.
Development version of IG: 0.x.x
IG status: draft
Artifacts status: draft with experimental flag set to true
Used during initial development and testing
Breaking changes may occur between minor versions
Production versions of IG: 1.x.x+
IG status: active
Artifacts status: active with experimental flag set to false
First stable release begins at 1.0.0
Follows strict SemVer compatibility rules
Further major version changes of IG: 2.x.x, 3.x.x, etc.
Same as production versions
Indicates breaking changes in parts of the IG or significant architectural updates
IP Statements
This publication includes IP covered under the following statements.
International Classification of Childhood Cancer, third edition (ICCC-3). Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. Cancer 2005;103(7):1457-1467. Published by the International Agency for Research on Cancer (IARC) and the US National Cancer Institute SEER Program.
International Classification of Diseases for Oncology, 3rd edition, 2nd revision. Copyright World Health Organization / International Agency for Research on Cancer. Source tables: IACR, https://www.iacr.com.fr (ICD-O-3.2 final table, 9 October 2020). Reproduced for the DHP terminology service; redistribution is subject to WHO/IARC permission. Uzbek and Russian designations are the Ministry of Health of the Republic of Uzbekistan translations.
International Classification of Health Interventions (ICHI), World Health Organization. Licensed under Creative Commons Attribution-NoDerivs 3.0 IGO (CC BY-ND 3.0 IGO). Reproduced in FHIR form without modification: every concept keeps its code, title and WHO URI. Translations of the classification and maps to other classifications require a separate agreement with WHO. The concepts marked inactive are not WHO content - they are codes a national source system still carries that WHO has withdrawn, kept so existing records remain readable, and they carry no WHO title or URI.
This material contains content that is copyright of SNOMED International. Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact https://www.snomed.org/get-snomed or info@snomed.org.
WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway. Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.
